4:45 PM ET
8-K
Other 8-K Filing
Pulse Biosciences Other 8-K Filing
Pulse Biosciences entered into a new equity distribution agreement with Mizuho Securities to establish an at-the-market (ATM) offering program for up to $85 million in common stock. This new facility replaces a previous August 2026 ATM program under which the company sold approximately $68.8 million in shares. As of this filing, no shares have been sold under the new $85 million agreement.
- Counterparty
- Mizuho Securities USA LLC